Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Internal and Emergency Medicine
Published in: Internal and Emergency Medicine 3/2016

01-04-2016 | IM - REVIEW

Lifestyle interventions in preventing new type 2 diabetes in Asian populations

Authors: Pietro Amedeo Modesti, Giorgio Galanti, Piergiuseppe Cala’, Maria Calabrese

Published in: Internal and Emergency Medicine | Issue 3/2016

Login to get access

Abstract

The aim of this study was to review current evidence on interventional studies aimed at the prevention of type 2 diabetes in Asian population with lifestyle interventions. Prevalence of type 2 diabetes sharply increased in most Asian countries during the last decades. This issue has now also relevant implication for Europe where different surveys are also consistently revealing an higher prevalence of type 2 diabetes and other and major CVD risk factors among subjects originating from Asian Countries than in the native population. Nutrition and lifestyle transition seem to play a role in disclosing the predisposition for the development of type 2 diabetes and great interest is now shown toward the possibility to intervene with lifestyle intervention on at risk populations. A meta-analysis of Randomized Controlled Trials showed that lifestyle interventions are highly effective also in the Asian population. All studies were, however, conducted with an individual approach based on the identification of high-risk individuals. When ethnic minority groups have to be addressed, an approach directed to the community rather than to the individual might, however, be more effective. This review reinforces the importance for policy-makers to consider the involvement of the whole community of minority immigrant groups with lifestyle intervention programs.
Appendix
Available only for authorised users
Literature
1.
Goldberg R, Temprosa M, Otvos J, Brunzell J, Marcovina S, Mather K, Arakaki R, Watson K, Horton E, Barrett-Connor E (2013) Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program. J Clin Endocrinol Metab 98(10):3989–3998. doi:10.​1210/​jc.​2013-1452 CrossRefPubMedPubMedCentral
2.
Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, Howard BV (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20(4):537–544. doi:10.​2337/​diacare.​20.​4.​537 CrossRefPubMed
3.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM, Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346(6):393–403. doi:10.​1056/​NEJMoa012512 CrossRefPubMed
4.
Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K, Hamalainen H, Harkonen P, Keinanen-Kiukaanniemi S, Laakso M, Louheranta A, Mannelin M, Paturi M, Sundvall J, Valle TT, Uusitupa M, Tuomilehto J (2006) Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet 368(9548):1673–1679. doi:10.​1016/​S0140-6736(06)69701-8 CrossRefPubMed
5.
6.
Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V (2006) The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia 49(2):289–297. doi:10.​1007/​s00125-005-0097-z CrossRefPubMed
7.
8.
9.
Fernandes RA, Coelho ESMJ, Spiguel Lima MC, Cayres SU, Codogno JS, Lira FS (2015) Possible underestimation by sports medicine of the effects of early physical exercise practice on the prevention of diseases in adulthood. Curr Diabetes Rev 11(3):201–205CrossRefPubMed
10.
Hopper I, Billah B, Skiba M, Krum H (2011) Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials. Eur J Cardiovasc Prev Rehabil 18(6):813–823. doi:10.​1177/​1741826711421687​ CrossRefPubMed
11.
12.
13.
Saaristo T, Moilanen L, Korpi-Hyovalti E, Vanhala M, Saltevo J, Niskanen L, Jokelainen J, Peltonen M, Oksa H, Tuomilehto J, Uusitupa M, Keinanen-Kiukaanniemi S (2010) Lifestyle intervention for prevention of type 2 diabetes in primary health care one-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care 33(10):2146–2151. doi:10.​2337/​Dc10-0410 CrossRefPubMedPubMedCentral
14.
15.
16.
Hermansen K, Baekdal TA, During M, Pietraszek A, Mortensen LS, Jorgensen H, Flint A (2013) Liraglutide suppresses postprandial triglyceride and apolipoprotein B48 elevations after a fat-rich meal in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, cross-over trial. Diabetes Obes Metab 15(11):1040–1048. doi:10.​1111/​dom.​12133 CrossRefPubMed
17.
McKeigue PM, Marmot MG, Syndercombe Court YD, Cottier DE, Rahman S, Riemersma RA (1988) Diabetes, hyperinsulinaemia, and coronary risk factors in Bangladeshis in east London. Br Heart J 60(5):390–396CrossRefPubMedPubMedCentral
18.
Shai I, Jiang R, Manson JE, Stampfer MJ, Willett WC, Colditz GA, Hu FB (2006) Ethnicity, obesity, and risk of type 2 diabetes in women—a 20-year follow-up study. Diabetes Care 29(7):1585–1590. doi:10.​2337/​Dc06-0057 CrossRefPubMed
19.
Khoo CM, Sairazi S, Taslim S, Gardner D, Wu Y, Lee J, van Dam RM, Tai ES (2011) Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population. Diabetes Care 34(5):1120–1126. doi:10.​2337/​Dc10-2097 CrossRefPubMedPubMedCentral
20.
21.
Ryden L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L, Ostergren J, Patrono C, Seferovic P, Uva MS, Taskinen MR, Tendera M, Tuomilehto J, Valensi P, Zamorano JL (2013) ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 34(39):3035–3087. doi:10.​1093/​eurheartj/​eht108 CrossRefPubMed
22.
23.
Barba C, Cavalli-Sforza T, Cutter J, Darnton-Hill I, Deurenberg P, Deurenberg-Yap M, Gill T, James P, Ko G, Miu AH, Kosulwat V, Kumanyika S, Kurpad A, Mascie-Taylor N, Moon HK, Nishida C, Noor MI, Reddy KS, Rush E, Schultz JT, Seidell J, Stevens J, Swinburn B, Tan K, Weisell R, Wu ZS, Yajnik CS, Yoshiike N, Zimmet P, Consultation WE (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403):157–163CrossRef
24.
25.
26.
Yajnik CS, Lubree HG, Rege SS, Naik SS, Deshpande JA, Deshpande SS, Joglekar CV, Yudkin JS (2002) Adiposity and hyperinsulinemia in Indians are present at birth. J Clin Endocr Metab 87(12):5575–5580. doi:10.​1210/​jc.​2002-020434 CrossRefPubMed
27.
Mckeigue PM, Pierpoint T, Ferrie JE, Marmot MG (1992) Relationship of glucose-intolerance and hyperinsulinemia to body-fat pattern in South Asians and Europeans. Diabetologia 35(8):785–791PubMed
28.
Who (2004) Appropriate body-mass index in Asian populations and its implications for policy and intervention strategies. Lancet 363(9412):902CrossRef
29.
Misra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Chadha D, Joshi SR, Sadikot S, Gupta R, Gulati S, Munjal YP, Concensus G (2009) Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Phys India 57:163–170
30.
Bei-Fan Z, Working CMAG (2002) Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults: study on optimal cut-off points of body mass index and waist circumference in Chinese adults. Asia Pac J Clin Nutr 11:S685–S693. doi:10.​1046/​j.​1440-6047.​11.​s8.​9.​x CrossRef
31.
32.
Edelstein SL, Knowler WC, Bain RP, Andres R, BarrettConnor EL, Dowse GK, Haffner SM, Pettitt DJ, Sorkin JD, Muller DC, Collins VR, Hamman RF (1997) Predictors of progression from impaired glucose tolerance to NIDDM—an analysis of six prospective studies. Diabetes 46(4):701–710. doi:10.​2337/​diabetes.​46.​4.​701 CrossRefPubMedPubMedCentral
33.
Shaw JA, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, Hemraj F, Fareed D, Tuomilehto J, Alberti KGMM (1999) Impaired fasting glucose or impaired glucose tolerance—what best predicts future diabetes in Mauritius? Diabetes Care 22(3):399–402. doi:10.​2337/​diacare.​22.​3.​399 CrossRefPubMed
34.
35.
Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC (2000) The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23(8):1108–1112. doi:10.​2337/​diacare.​23.​8.​1108 CrossRefPubMed
36.
de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ (2001) Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population—the Hoorn study. JAMA 285(16):2109–2113. doi:10.​1001/​jama.​285.​16.​2109 CrossRefPubMed
37.
Gerstein HC, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, Yazdi H, Booker L (2007) Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 78(3):305–312. doi:10.​1016/​j.​diabres.​2007.​05.​004 CrossRefPubMed
38.
Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD (1998) Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults—the Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 21(4):518–524. doi:10.​2337/​diacare.​21.​4.​518 CrossRefPubMed
39.
Stern MP, Williams K, Haffner SA (2002) Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? Ann Intern Med 136(8):575–581CrossRefPubMed
40.
Modesti PA, Bianchi S, Borghi C, Cameli M, Capasso G, Ceriello A, Ciccone MM, Germano G, Maiello M, Muiesan ML, Novo S, Padeletti L, Palmiero P, Pillon S, Rotella CM, Saba PS, Scicchitano P, Trimarco B, Volpe M, Pedrinelli R, Di Biase M (2014) Cardiovascular health in migrants: current status and issues for prevention. A collaborative multidisciplinary task force report. J Cardiovasc Med 15(9):683–692. doi:10.​2459/​Jcm.​0000000000000069​ CrossRef
41.
42.
Kengne AP, Beulens JWJ, Peelen LM, Moons KGM, van der Schouw YT, Schulze MB, Spijkerman AMW, Griffin SJ, Grobbee DE, Palla L, Tormo MJ, Arriola L, Barengo NC, Barricarte A, Boeing H, Bonet C, Clavel-Chapelon F, Dartois L, Fagherazzi G, Franks PW, Huerta JM, Kaaks R, Key TJ, Khaw KT, Li KR, Muhlenbruch K, Nilsson PM, Overvad K, Overvad TF, Palli D, Panico S, Quiros JR, Rolandsson O, Roswall N, Sacerdote C, Sanchez MJ, Slimani N, Tagliabue G, Tjonneland A, Tumino R, van der A DL, Forouhi NG, Sharp SJ, Langenberg C, Riboli E, Wareham NJ (2014) Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models. Lancet Diabetes Endocrinol 2(1):19–29. doi:10.​1016/​S2213-8587(13)70103-7 CrossRefPubMed
43.
44.
45.
46.
47.
Abbasi A, Peelen LM, Corpeleijn E, van der Schouw YT, Stolk RP, Spijkerman AMW, van der A DL, Moons KGM, Navis G, Bakker SJL, Beulens JWJ (2012) Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ. doi:10.​1136/​bmj.​e5900 PubMedPubMedCentral
48.
Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, Folsom AR, Chambless LE (2005) Identifying individuals at high risk for diabetes—the Atherosclerosis Risk in Communities study. Diabetes Care 28(8):2013–2018. doi:10.​2337/​diacare.​28.​8.​2013 CrossRefPubMed
49.
Kahn HS, Cheng YJ, Thompson TJ, Imperatore G, Gregg EW (2009) Two risk-scoring systems for predicting incident diabetes mellitus in US adults age 45–64 years. Ann Intern Med 150(11):741–751CrossRefPubMed
50.
Chen L, Magliano DJ, Balkau B, Colagiuri S, Zimmet PZ, Tonkin AM, Mitchell P, Phillips PJ, Shaw JE (2010) AUSDRISK: an Australian type 2 diabetes risk assessment tool based on demographic, lifestyle and simple anthropometric measures. Med J Aust 192(4):197–202PubMed
51.
Rosella LC, Manuel DG, Burchill C, Stukel TA, team ftP-D (2011) A population-based risk algorithm for the development of diabetes: development and validation of the Diabetes Population Risk Tool (DPoRT). J Epidemiol Commun Health 65(7):613–620. doi:10.​1136/​jech.​2009.​102244 CrossRef
52.
Hippisley-Cox J, Coupland C, Robson J, Sheikh A, Brindle P (2009) Predicting risk of type 2 diabetes in England and Wales: prospective derivation and validation of QDScore. BMJ. doi:10.​1136/​bmj.​b880
53.
54.
Merlotti C, Morabito A, Pontiroli AE (2014) Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab 16(8):719–727. doi:10.​1111/​dom.​12270 CrossRefPubMed
55.
Saito T, Watanabe M, Nishida J, Izumi T, Omura M, Takagi T, Fukunaga R, Bandai Y, Tajima N, Nakamura Y, Ito M (2011) Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels A Randomized Controlled Trial. Arch Intern Med 171(15):1352–1360CrossRefPubMed
56.
Sakane N, Sato J, Tsushita K, Tsujii S, Kotani K, Tsuzaki K, Tominaga M, Kawazu S, Sato Y, Usui T, Kamae I, Yoshida T, Kiyohara Y, Sato S, Kuzuya H (2011) Prevention of type 2 diabetes in a primary healthcare setting: three-year results of lifestyle intervention in Japanese subjects with impaired glucose tolerance. BMC Public Health 11(1):40. doi:10.​1186/​1471-2458-11-40 CrossRefPubMedPubMedCentral
57.
58.
Ramachandran A, Snehalatha C, Ram J, Selvam S, Simon M, Nanditha A, Shetty AS, Godsland IF, Chaturvedi N, Majeed A, Oliver N, Toumazou C, Alberti KG, Johnston DG (2013) Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial. Lancet Diabetes Endocrinol 1(3):191–198. doi:10.​1016/​S2213-8587(13)70067-6 CrossRefPubMed
59.
Bhopal RS, Douglas A, Wallia S, Forbes JF, Lean ME, Gill JM, McKnight JA, Sattar N, Sheikh A, Wild SH, Tuomilehto J, Sharma A, Bhopal R, Smith JB, Butcher I, Murray GD (2014) Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial. Lancet Diabetes Endocrinol 2(3):218–227. doi:10.​1016/​s2213-8587(13)70204-3 CrossRefPubMed
60.
National_Diabetes_Research_Group (1981) A mass survey of diabetes mellitus in a population of 300,000 in 14 provinces and municipalities in China (author’s transl). Zhonghua Nei Ke Za Zhi 20(11):678–683
61.
62.
Li GW, Zhang P, Wang JP, Gregg EW, Yang WY, Gong QH, Li H, Li HL, Jiang YY, An YL, Shuai Y, Zhang B, Zhang JL, Thompson TJ, Gerzoff RB, Roglic G, Hu YH, Bennett PH (2008) The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 371(9626):1783–1789. doi:10.​1016/​S0140-6736(08)60766-7 CrossRefPubMed
63.
Xu Y, Wang L, He J, Bi Y, Li M, Wang T, Wang L, Jiang Y, Dai M, Lu J, Xu M, Li Y, Hu N, Li J, Mi S, Chen CS, Li G, Mu Y, Zhao J, Kong L, Chen J, Lai S, Wang W, Zhao W, Ning G (2013) Prevalence and control of diabetes in Chinese adults. JAMA 310(9):948–959. doi:10.​1001/​jama.​2013.​168118 CrossRefPubMed
64.
65.
66.
Admiraal WM, Vlaar EM, Nierkens V, Holleman F, Middelkoop BJ, Stronks K, van Valkengoed IG (2013) Intensive lifestyle intervention in general practice to prevent type 2 diabetes among 18–60-year-old South Asians: 1-year effects on the weight status and metabolic profile of participants in a randomized controlled trial. PLoS One 8(7):e68605. doi:10.​1371/​journal.​pone.​0068605 CrossRefPubMedPubMedCentral
67.
Rose G (1981) Strategy of prevention: lessons from cardiovascular disease. Br Med J (Clin Res Ed) 282(6279):1847–1851CrossRef
68.
69.
Zhou M, Astell-Burt T, Bi Y, Feng X, Jiang Y, Li Y, Page A, Wang L, Xu Y, Wang L, Zhao W, Ning G (2015) Geographical variation in diabetes prevalence and detection in china: multilevel spatial analysis of 98,058 adults. Diabetes Care 38(1):72–81. doi:10.​2337/​dc14-1100 CrossRefPubMedPubMedCentral
70.
Modesti PA, Han Y, Jing Y, Xiaoling W, Mengyue Z, Zihua Y, Jia G, Perruolo E, Bini L, Camera M, Biggeri A, Rapi S, Hongsheng C, Li Z, Zengli W, Jianbin H, Xiaoyue Z, Zhao D (2014) Design and arrangement of the CHIP (CHinese In Prato) study. Epidemiol Prev 38(6):357–363PubMed
71.
72.
73.
Artinian NT, Fletcher GF, Mozaffarian D, Kris-Etherton P, Van Horn L, Lichtenstein AH, Kumanyika S, Kraus WE, Fleg JL, Redeker NS, Meininger JC, Banks J, Stuart-Shor EM, Fletcher BJ, Miller TD, Hughes S, Braun LT, Kopin LA, Berra K, Hayman LL, Ewing LJ, Ades PA, Durstine JL, Houston-Miller N, Burke LE, American Heart Association Prevention Committee of the Council on Cardiovascular N (2010) Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation 122(4):406–441. doi:10.​1161/​CIR.​0b013e3181e8edf1​ CrossRefPubMed
Metadata
Title
Lifestyle interventions in preventing new type 2 diabetes in Asian populations
Authors
Pietro Amedeo Modesti
Giorgio Galanti
Piergiuseppe Cala’
Maria Calabrese
Publication date
01-04-2016
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 3/2016
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-015-1325-2

Other articles of this Issue 3/2016

Internal and Emergency Medicine 3/2016 Go to the issue

IM - ORIGINAL

Role of clinical and pulmonary computed tomography angiographic parameters in the prediction of short- and long-term mortality in patients with pulmonary embolism

IM - CASE RECORD

An uncommon cause of syncope

IM - REVIEW

Prevention programs for chronic kidney disease in low-income countries

IM - REVIEW

Focus on migrants with type 2 diabetes mellitus in European Countries

IM - ORIGINAL

Relationship between left ventricular mechanics and low free triiodothyronine levels after myocardial infarction: a prospective study

IM - ORIGINAL

Clinical significance of pelvic lymph node status in prostate cancer: review of 1690 cases
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits